Health and Healthcare

Merck : MRK

All Merck Articles

1067 Articles

Lee Jackson | Dec 9, 2014 at 8:50 AM EST

After Big Cubist Buy, Are These 2 Stocks Next to Be Acquired?

SunTrust Robinson Humphrey analysts say in a research note that Achaogen and Cempra could be in play as acquisition targets.

Paul Ausick | Dec 8, 2014 at 8:20 AM EST

Merck, Cubist Agree to $9.5 Billion Acquisition

Merck will acquire Cubist for $102 a share, or, about $9.5 billion, including $1.1 billion in Cubist’s net debt and…

Chris Lange | Nov 24, 2014 at 9:15 AM EST

Big News for Ebola Stocks

Monday may have started out as a fairly quiet news day for most stock sectors on a shortened week, but…

Paul Ausick | Nov 18, 2014 at 9:10 AM EST

Companies Spending the Most on R&D

For the third consecutive year, the company spending the most on research and development (R&D) was Germany's Volkswagen.

Paul Ausick | Nov 14, 2014 at 4:48 PM EST

The 4 DJIA Stocks That Weighed Down Friday’s Market

thinkstockNovember 14, 2014: Markets opened mixed on Friday following a jump in U.S. consumer sentiment coupled with better-than-expected reports on…

Lee Jackson | Nov 13, 2014 at 9:15 AM EST

4 Top Pharmaceutical Companies Helping Combat Hepatitis C Near Epidemic

A new research report from the analysts at UBS focuses on four companies that stand to benefit from rising demand…

Paul Ausick | Oct 30, 2014 at 4:01 PM EDT

The 4 DJIA Stocks That Dominated the Market

thinkstockOctober 30, 2014: Markets opened mixed again on Thursday with the DJIA opening higher on the strength of a big…

Paul Ausick | Oct 27, 2014 at 4:01 PM EDT

The 4 DJIA Stocks That Guided Markets to a Mixed Close

thinkstockOctober 27, 2014: Markets opened lower on Monday as traders hit back at Brazilian voters who re-elected Dilma Rousseff as…

Chris Lange | Oct 27, 2014 at 8:40 AM EDT

Merck Earnings Look Very Mixed in Major Restructuring

Merck reported better-than-expected third-quarter earnings Monday morning.

Jon C. Ogg | Oct 24, 2014 at 8:05 AM EDT

Pfizer Stock Buyback Plan Just Too Large to Ignore — It Is on Viagra

Pfizer's new buyback is simply too large and too significant to ignore, and it might jokingly be called "on Viagra."

Paul Ausick | Oct 13, 2014 at 4:01 PM EDT

The 4 DJIA Stocks Sank the Market

thinkstockOctober 13, 2014: Markets opened lower on Monday, a holiday for all but the equity markets. There was no economic…

Jon C. Ogg | Oct 10, 2014 at 9:30 AM EDT

Short Sellers Getting Smart in Defensive High-Yield Dividend Stocks

Short sellers have decided to get out of some of the go-to defensive stocks with high-dividend yields in late September.

Paul Ausick | Oct 8, 2014 at 4:01 PM EDT

The 4 Stocks That Dominated the Market

thinkstockOctober 8, 2014: Markets opened mixed on Wednesday with virtually no economic data and little other news until the release…

Paul Ausick | Oct 3, 2014 at 4:01 PM EDT

The 4 Stocks That Boosted the Market

thinkstockOctober 3, 2014: Markets opened higher on Friday following the report on September non-farm payrolls which showed better-than-expected improvement. The…

Jon C. Ogg | Sep 29, 2014 at 4:05 PM EDT

The Best- and Worst-Performing DJIA Stocks in 2014

The bull market may be five and a half years old, but stocks have been fighting each week to hit…

1 … 44 45 46 47 48 … 72

Merck : MRK

All Merck Articles

After Big Cubist Buy, Are These 2 Stocks Next to Be Acquired?

Merck, Cubist Agree to $9.5 Billion Acquisition

Big News for Ebola Stocks

Companies Spending the Most on R&D

The 4 DJIA Stocks That Weighed Down Friday’s Market

4 Top Pharmaceutical Companies Helping Combat Hepatitis C Near Epidemic

The 4 DJIA Stocks That Dominated the Market

The 4 DJIA Stocks That Guided Markets to a Mixed Close

Merck Earnings Look Very Mixed in Major Restructuring

Pfizer Stock Buyback Plan Just Too Large to Ignore — It Is on Viagra

The 4 DJIA Stocks Sank the Market

Short Sellers Getting Smart in Defensive High-Yield Dividend Stocks

The 4 Stocks That Dominated the Market

The 4 Stocks That Boosted the Market

The Best- and Worst-Performing DJIA Stocks in 2014

MISL Investors: Watch the FY27 Budget Bill Before the Next Rally

SMH Has Crushed the S&P 500 by 2,041% Over a Decade, But Recent 42% Rally Signals Dangerous Valuations

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

MISL Investors: Watch the FY27 Budget Bill Before the Next Rally

SMH Has Crushed the S&P 500 by 2,041% Over a Decade, But Recent 42% Rally Signals Dangerous Valuations

Merck : MRK

All Merck Articles

After Big Cubist Buy, Are These 2 Stocks Next to Be Acquired?

Merck, Cubist Agree to $9.5 Billion Acquisition

Big News for Ebola Stocks

Companies Spending the Most on R&D

The 4 DJIA Stocks That Weighed Down Friday’s Market

4 Top Pharmaceutical Companies Helping Combat Hepatitis C Near Epidemic

The 4 DJIA Stocks That Dominated the Market

The 4 DJIA Stocks That Guided Markets to a Mixed Close

Merck Earnings Look Very Mixed in Major Restructuring

Pfizer Stock Buyback Plan Just Too Large to Ignore — It Is on Viagra

The 4 DJIA Stocks Sank the Market

Short Sellers Getting Smart in Defensive High-Yield Dividend Stocks

The 4 Stocks That Dominated the Market

The 4 Stocks That Boosted the Market

The Best- and Worst-Performing DJIA Stocks in 2014

MISL Investors: Watch the FY27 Budget Bill Before the Next Rally

SMH Has Crushed the S&P 500 by 2,041% Over a Decade, But Recent 42% Rally Signals Dangerous Valuations

This High-Yield Emerging Funds ETF Offers International Diversification

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%